Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Sanofi says any offer for Horizon Therapeutics, if made, to be 'solely in cash' » 07:57
12/02/22
12/02
07:57
12/02/22
07:57
SNY

Sanofi

$45.87 /

+0.52 (+1.15%)

, HZNP

Horizon Therapeutics

$100.88 /

+0.62 (+0.62%)

Sanofi (SNY) issued the…

Sanofi (SNY) issued the following statement regarding rule 2.12 of the takeover rules: "Sanofi S.A. confirms that any offer for Horizon Therapeutics plc, if made by Sanofi, will be solely in cash. There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming."

ShowHide Related Items >><<
SNY Sanofi
$45.87 /

+0.52 (+1.15%)

HZNP Horizon Therapeutics
$100.88 /

+0.62 (+0.62%)

SNY Sanofi
$45.87 /

+0.52 (+1.15%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
HZNP Horizon Therapeutics
$100.88 /

+0.62 (+0.62%)

11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
SNY Sanofi
$45.87 /

+0.52 (+1.15%)

HZNP Horizon Therapeutics
$100.88 /

+0.62 (+0.62%)

SNY Sanofi
$45.87 /

+0.52 (+1.15%)

HZNP Horizon Therapeutics
$100.88 /

+0.62 (+0.62%)

SNY Sanofi
$45.87 /

+0.52 (+1.15%)

HZNP Horizon Therapeutics
$100.88 /

+0.62 (+0.62%)

SNY Sanofi
$45.87 /

+0.52 (+1.15%)

HZNP Horizon Therapeutics
$100.88 /

+0.62 (+0.62%)

Thursday
Recommendations
Horizon Therapeutics price target raised to $125 from $101 at Jefferies » 08:50
12/01/22
12/01
08:50
12/01/22
08:50
HZNP

Horizon Therapeutics

$100.26 /

+21.51 (+27.31%)

, SNY

Sanofi

$45.35 /

-0.535 (-1.17%)

, AMGN

Amgen

$286.51 /

+4.49 (+1.59%)

, JNJ

Johnson & Johnson

$177.94 /

+1.895 (+1.08%)

Jefferies analyst Akash…

Jefferies analyst Akash Tewari raised the firm's price target on Horizon Therapeutics (HZNP) to $125 from $101 and keeps a Buy rating on the shares after Horizon confirmed "highly preliminary discussions" with Sanofi (SNY), Amgen (AMGN) and Johnson & Johnson's (JNJ) Janssen about potentially being acquired. Tewari thinks a deal happens at about $25B-$30B in value and puts about 85% odds on a deal getting done.

ShowHide Related Items >><<
SNY Sanofi
$45.35 /

-0.535 (-1.17%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
10/25/22 Piper Sandler
Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
SNY Sanofi
$45.35 /

-0.535 (-1.17%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
AMGN Amgen
$286.51 /

+4.49 (+1.59%)

11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
11/08/22 Oppenheimer
Amgen price target raised to $300 from $290 at Oppenheimer
11/08/22 Truist
Amgen price target raised to $280 from $266 at Truist
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
SNY Sanofi
$45.35 /

-0.535 (-1.17%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

Hot Stocks
Regeneron's fianlimab and Libtayo featured in solid tumor presentations » 07:14
12/01/22
12/01
07:14
12/01/22
07:14
REGN

Regeneron

$751.41 /

+16.46 (+2.24%)

Regeneron announced new…

Regeneron announced new and updated data across its oncology pipeline to be presented at the European Society for Medical Oncology Immuno-Oncology - ESMO IO - Congress from December 7-9 in Geneva. Presentation highlights include first clinical results and new exploratory analyses from trials investigating LAG-3 inhibitor fianlimab and/or PD-1 inhibitor Libtayo - cemiplimab - in non-small cell lung cancer, melanoma and cervical cancer. Israel Lowy, Senior VP, Translational and Clinical Sciences, Oncology at Regeneron, said: "Libtayo has already proven to be an effective immunotherapy across multiple tumor types and is poised to serve as a foundational therapy for our investigational combination approaches. Fianlimab combined with Libtayo has generated early-but-promising clinical activity in advanced melanoma and non-small cell lung cancer, demonstrating the potential of Regeneron's oncology pipeline to potentially advance the standard-of-care in various cancers." Efficacy results demonstrated an objective response rate of 27% - 4 of 15 patients -. Additionally, exploratory analyses of the naive cohort found the ORR was 50% among those who had not received any prior systemic therapy and 100% among those with tumors that had greater than or equal to 50% PD-L1 expression. Median duration of response was not reached in the naive cohort and was 5 months in the experienced cohort. Rates of greater than or equal to grade 3 adverse events were respectively 33% and 40%, while rates of serious AEs were respectively 20% and 13%. There were no treatment-related deaths reported in either cohort.

ShowHide Related Items >><<
REGN Regeneron
$751.41 /

+16.46 (+2.24%)

REGN Regeneron
$751.41 /

+16.46 (+2.24%)

11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/09/22 Truist
Regeneron price target raised to $856 from $790 at Truist
11/03/22 Piper Sandler
Regeneron price target lowered to $765 from $775 at Piper Sandler
10/31/22 EF Hutton
Regeneron initiated with a Buy at EF Hutton
REGN Regeneron
$751.41 /

+16.46 (+2.24%)

REGN Regeneron
$751.41 /

+16.46 (+2.24%)

REGN Regeneron
$751.41 /

+16.46 (+2.24%)

REGN Regeneron
$751.41 /

+16.46 (+2.24%)

Wednesday
On The Fly
What You Missed On Wall Street On Wednesday » 16:33
11/30/22
11/30
16:33
11/30/22
16:33
CNI

Canadian National

$128.40 /

+3.2 (+2.56%)

, CP

Canadian Pacific

$81.93 /

+1.615 (+2.01%)

, CSX

CSX

$32.71 /

+0.53 (+1.65%)

, KSU

Kansas City Southern

$293.64 /

+ (+0.00%)

, NSC

Norfolk Southern

$256.40 /

+3.09 (+1.22%)

, UNP

Union Pacific

$217.49 /

+4.625 (+2.17%)

, HPE

HP Enterprise

$16.79 /

+1.325 (+8.57%)

, HZNP

Horizon Therapeutics

$100.26 /

+21.51 (+27.31%)

, AMGN

Amgen

$286.51 /

+4.49 (+1.59%)

, JNJ

Johnson & Johnson

$177.94 /

+1.895 (+1.08%)

, SNY

Sanofi

$45.35 /

-0.535 (-1.17%)

, INTU

Intuit

$407.32 /

+26.2 (+6.87%)

, HRL

Hormel Foods

$46.99 /

-1.175 (-2.44%)

, $ECON

Economic Data

/

+

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$407.47 /

+12.2 (+3.09%)

, CRWD

Crowdstrike

$117.56 /

-20.62 (-14.92%)

, FSR

Fisker

$7.73 /

+0.455 (+6.25%)

, RIVN

Rivian Automotive

$32.05 /

+3.195 (+11.07%)

, LCID

Lucid Group

$10.12 /

+0.355 (+3.64%)

, COO

Cooper Companies

$316.13 /

+8.85 (+2.88%)

, CVNA

Carvana

$7.69 /

+0.355 (+4.84%)

, NTR

Nutrien

$80.44 /

-1.17 (-1.43%)

, AREC

American Resources

$1.51 /

-0.16 (-9.61%)

, UBS

UBS

$18.44 /

+0.185 (+1.01%)

, ABNB

Airbnb

$102.20 /

+6.8 (+7.13%)

, PINS

Pinterest

$25.40 /

+1.395 (+5.81%)

, XPEV

XPeng

$10.83 /

+3.48 (+47.35%)

, BIDU

Baidu

$108.65 /

+8.93 (+8.96%)

, SLDP

Solid Power

$3.66 /

-0.62 (-14.49%)

, ASTS

AST SpaceMobile

$5.77 /

-0.58 (-9.13%)

, NTAP

NetApp

$67.59 /

-4.195 (-5.84%)

, WDAY

Workday

$167.70 /

+24.325 (+16.97%)

, LESL

Leslie's

$14.61 /

-0.475 (-3.15%)

, WOOF

Petco

$11.06 /

+1.585 (+16.73%)

, CRL

Charles River

$228.53 /

-10.91 (-4.56%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

WOOF Petco
$11.06 /

+1.585 (+16.73%)

WDAY Workday
$167.70 /

+24.325 (+16.97%)

UNP Union Pacific
$217.49 /

+4.625 (+2.17%)

UBS UBS
$18.44 /

+0.185 (+1.01%)

SPY SPDR S&P 500 ETF Trust
$407.47 /

+12.2 (+3.09%)

SPX S&P 500
/

+

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

SLDP Solid Power
$3.66 /

-0.62 (-14.49%)

RIVN Rivian Automotive
$32.05 /

+3.195 (+11.07%)

PINS Pinterest
$25.40 /

+1.395 (+5.81%)

NTR Nutrien
$80.44 /

-1.17 (-1.43%)

NTAP NetApp
$67.59 /

-4.195 (-5.84%)

NSC Norfolk Southern
$256.40 /

+3.09 (+1.22%)

LESL Leslie's
$14.61 /

-0.475 (-3.15%)

LCID Lucid Group
$10.12 /

+0.355 (+3.64%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

INTU Intuit
$407.32 /

+26.2 (+6.87%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

HRL Hormel Foods
$46.99 /

-1.175 (-2.44%)

HPE HP Enterprise
$16.79 /

+1.325 (+8.57%)

FSR Fisker
$7.73 /

+0.455 (+6.25%)

CVNA Carvana
$7.69 /

+0.355 (+4.84%)

CSX CSX
$32.71 /

+0.53 (+1.65%)

CRWD Crowdstrike
$117.56 /

-20.62 (-14.92%)

CRL Charles River
$228.53 /

-10.91 (-4.56%)

CP Canadian Pacific
$81.93 /

+1.615 (+2.01%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

CNI Canadian National
$128.40 /

+3.2 (+2.56%)

BIDU Baidu
$108.65 /

+8.93 (+8.96%)

ASTS AST SpaceMobile
$5.77 /

-0.58 (-9.13%)

AREC American Resources
$1.51 /

-0.16 (-9.61%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

ABNB Airbnb
$102.20 /

+6.8 (+7.13%)

$ECON Economic Data
/

+

CNI Canadian National
$128.40 /

+3.2 (+2.56%)

11/29/22 BofA
Canadian National price target raised to $140 from $131 at BofA
10/26/22 BMO Capital
Canadian National price target raised to C$180 from C$170 at BMO Capital
10/26/22 Scotiabank
Canadian National price target raised to C$159 from C$156 at Scotiabank
10/26/22 Barclays
Canadian National price target raised to $118 from $110 at Barclays
CP Canadian Pacific
$81.93 /

+1.615 (+2.01%)

11/28/22 Deutsche Bank
Deutsche upgrades 'highest quality railroad' Canadian Pacific to Buy
11/28/22 Deutsche Bank
Canadian Pacific upgraded to Buy from Hold at Deutsche Bank
10/27/22 Scotiabank
Canadian Pacific price target raised to C$102 from C$100 at Scotiabank
10/27/22 Barclays
Canadian Pacific price target raised to $81 from $77 at Barclays
CSX CSX
$32.71 /

+0.53 (+1.65%)

11/29/22 Barclays
CSX price target raised to $38 from $35 at Barclays
11/28/22 Deutsche Bank
CSX price target raised to $39 from $36 at Deutsche Bank
10/24/22 Deutsche Bank
CSX price target lowered to $36 from $41 at Deutsche Bank
10/14/22 Vertical Research
CSX upgraded to Buy from Hold at Vertical Research
KSU Kansas City Southern
$293.64 /

+ (+0.00%)

06/27/22 Credit Suisse
Canadian National initiated with a Neutral at Credit Suisse
03/10/22 JPMorgan
JPMorgan resumes Canadian Pacific at Overweight, adds to Focus List
12/20/21 Evercore ISI
Canadian Pacific resumed at Outperform from In Line at Evercore ISI
NSC Norfolk Southern
$256.40 /

+3.09 (+1.22%)

11/29/22 Citi
Norfolk Southern price target raised to $250 from $225 at Citi
11/28/22 Deutsche Bank
Norfolk Southern price target raised to $273 from $220 at Deutsche Bank
11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Norfolk Southern downgraded to Peer Perform from Outperform at Wolfe Research
UNP Union Pacific
$217.49 /

+4.625 (+2.17%)

11/28/22 Deutsche Bank
Union Pacific price target raised to $238 from $216 at Deutsche Bank
11/01/22 RBC Capital
Union Pacific cut to Underperform at RBC Capital on weak operating performance
11/01/22 RBC Capital
Union Pacific downgraded to Underperform from Sector Perform at RBC Capital
10/24/22 Deutsche Bank
Union Pacific price target lowered to $216 from $232 at Deutsche Bank
HPE HP Enterprise
$16.79 /

+1.325 (+8.57%)

11/30/22 Susquehanna
HP Enterprise price target raised to $16 from $15 at Susquehanna
11/30/22 Deutsche Bank
HP Enterprise price target raised to $16 from $15 at Deutsche Bank
11/30/22 Morgan Stanley
HP Enterprise price target raised to $13 from $12 at Morgan Stanley
11/30/22 Citi
HP Enterprise price target raised to $13 from $11.50 at Citi
HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
10/25/22 Piper Sandler
Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
AMGN Amgen
$286.51 /

+4.49 (+1.59%)

11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
11/08/22 Oppenheimer
Amgen price target raised to $300 from $290 at Oppenheimer
11/08/22 Truist
Amgen price target raised to $280 from $266 at Truist
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
SNY Sanofi
$45.35 /

-0.535 (-1.17%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
INTU Intuit
$407.32 /

+26.2 (+6.87%)

12/01/22 Citi
Intuit price target lowered to $462 from $498 at Citi
11/30/22 Oppenheimer
Intuit price target lowered to $476 from $516 at Oppenheimer
11/30/22 Wells Fargo
Intuit price target lowered to $475 from $525 at Wells Fargo
11/30/22 Deutsche Bank
Intuit price target lowered to $525 from $560 at Deutsche Bank
HRL Hormel Foods
$46.99 /

-1.175 (-2.44%)

09/22/22 Argus
Hormel Foods price target lowered to $53 from $54 at Argus
09/02/22 Piper Sandler
Hormel Foods price target lowered to $47 from $48 at Piper Sandler
08/23/22 Stephens
Hormel Foods price target raised to $55 from $50 at Stephens
03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
$ECON Economic Data
/

+

10/31/22 JPMorgan
Central bank tightening has likely peaked, says JPMorgan
10/07/22 JPMorgan
JPMorgan changes November rate hike assumption after jobs data
09/26/22 JPMorgan
JPMorgan says stocks oversold amid 'encouraging' inflation signs
09/23/22 Goldman Sachs
Goldman Sachs lowers S&P 500 year-end target to 3,600
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$407.47 /

+12.2 (+3.09%)

CRWD Crowdstrike
$117.56 /

-20.62 (-14.92%)

12/01/22 Redburn
Crowdstrike initiated with a Buy at Redburn
12/01/22 Wolfe Research
Crowdstrike downgraded to Peer Perform from Outperform at Wolfe Research
11/30/22 Truist
Crowdstrike price target lowered to $200 from $275 at Truist
11/30/22 RBC Capital
Crowdstrike price target lowered to $165 from $200 at RBC Capital
FSR Fisker
$7.73 /

+0.455 (+6.25%)

11/29/22 Evercore ISI
Fisker initiated with an Outperform, $15 price target at Evercore ISI
11/29/22 Evercore ISI
Fisker initiated with an Outperform at Evercore ISI
11/03/22 RBC Capital
Fisker cut to Sector Perform at RBC Capital amid growing execution risk
11/03/22 RBC Capital
Fisker downgraded to Sector Perform from Outperform at RBC Capital
RIVN Rivian Automotive
$32.05 /

+3.195 (+11.07%)

11/29/22 Evercore ISI
Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
11/29/22 Evercore ISI
Rivian Automotive initiated with an In Line at Evercore ISI
11/10/22 RBC Capital
Rivian Automotive price target lowered to $50 from $61 at RBC Capital
11/10/22 Deutsche Bank
Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
LCID Lucid Group
$10.12 /

+0.355 (+3.64%)

11/29/22 Evercore ISI
Lucid Group initiated with an In Line, $12 price target at Evercore ISI
11/29/22 Evercore ISI
Lucid Group initiated with an In Line at Evercore ISI
11/10/22 R.F. Lafferty
Lucid Group price target lowered to $17 from $19 at R.F. Lafferty
09/27/22 Cantor Fitzgerald
Lucid Group initiated with an Overweight at Cantor Fitzgerald
COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

11/30/22 Baird
Cooper Companies upgraded to Outperform from Neutral at Baird
11/28/22 JPMorgan
Cooper Companies price target raised to $330 from $300 at JPMorgan
11/03/22 Piper Sandler
Cooper Companies price target lowered to $355 from $375 at Piper Sandler
10/11/22 Jefferies
Cooper Companies downgraded to Hold from Buy at Jefferies
CVNA Carvana
$7.69 /

+0.355 (+4.84%)

11/30/22 BofA
BofA downgrades Carvana to Neutral on liquidity concerns
11/30/22 BofA
Carvana downgraded to Neutral from Buy at BofA
11/22/22 Baird
Carvana downgraded to Neutral from Outperform at Baird
11/21/22 Cowen
Carvana downgraded to Market Perform from Outperform at Cowen
NTR Nutrien
$80.44 /

-1.17 (-1.43%)

11/29/22 Piper Sandler
Nutrien downgraded to Neutral from Overweight at Piper Sandler
11/17/22 Barclays
Nutrien price target lowered to $95 from $105 at Barclays
11/03/22 Morgan Stanley
Morgan Stanley expects negative response to Nutrien results and buyback delay
11/03/22 Scotiabank
Nutrien downgraded to Sector Perform from Outperform at Scotiabank
AREC American Resources
$1.51 /

-0.16 (-9.61%)

UBS UBS
$18.44 /

+0.185 (+1.01%)

10/26/22 JPMorgan
UBS price target raised to CHF 20.70 from CHF 20 at JPMorgan
10/26/22 Deutsche Bank
UBS price target raised to CHF 22 from CHF 21 at Deutsche Bank
10/26/22 RBC Capital
UBS price target raised to CHF 20 from CHF 19 at RBC Capital
10/26/22 Morgan Stanley
UBS price target raised to CHF 20 from CHF 18.50 at Morgan Stanley
ABNB Airbnb
$102.20 /

+6.8 (+7.13%)

11/22/22 Barclays
Airbnb price target raised to $103 from $101 at Barclays
11/22/22 Baird
Airbnb downgraded to Neutral from Outperform at Baird
11/17/22 Citi
Airbnb supply growth should continue to ramp, says Citi
11/02/22 Evercore ISI
Airbnb removed for 'TAP Outperform' list at Evercore ISI
PINS Pinterest
$25.40 /

+1.395 (+5.81%)

10/31/22 Citi
Pinterest price target raised to $26 from $25 at Citi
10/28/22 Stifel
Pinterest 'a rare bright spot thus far through earnings,' says Stifel
10/28/22 Barclays
Pinterest price target raised to $25 from $23 at Barclays
10/28/22 Piper Sandler
Pinterest price target raised to $25 from $23 at Piper Sandler
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/28/22 Jefferies
XPeng downgraded to Underperform from Hold at Jefferies
11/22/22 DBS Bank
XPeng initiated with a Buy at DBS Bank (earlier)
11/17/22 UBS
XPeng upgraded to Buy from Neutral at UBS
BIDU Baidu
$108.65 /

+8.93 (+8.96%)

11/23/22 Morgan Stanley
Baidu price target lowered to $120 from $140 at Morgan Stanley
11/23/22 Benchmark
Baidu price target lowered to $200 from $270 at Benchmark
11/23/22 Mizuho
Baidu price target lowered to $180 from $200 at Mizuho
11/23/22 Citi
Baidu price target lowered to $166 from $169 at Citi
SLDP Solid Power
$3.66 /

-0.62 (-14.49%)

11/30/22 DA Davidson
Solid Power cut to Neutral at DA Davidson on sudden announcement of CEO retiring
11/30/22 DA Davidson
Solid Power downgraded to Neutral from Buy at DA Davidson
10/31/22 Cowen
Solid Power initiated with a Market Perform at Cowen
06/29/22 Chardan
Solid Power initiated with a Buy at Chardan
ASTS AST SpaceMobile
$5.77 /

-0.58 (-9.13%)

11/23/22 Deutsche Bank
AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
10/28/22 B. Riley
AST SpaceMobile initiated with a Buy at B. Riley
10/19/22 Barclays
AST SpaceMobile price target lowered to $15 from $29 at Barclays
08/17/22 Deutsche Bank
AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
NTAP NetApp
$67.59 /

-4.195 (-5.84%)

11/30/22 Northland
NetApp price target lowered to $99 from $101 at Northland
11/30/22 Wells Fargo
NetApp price target lowered to $70 from $85 at Wells Fargo
11/30/22 Cowen
NetApp price target lowered to $80 from $93 at Cowen
11/30/22 Wedbush
NetApp price target lowered to $70 from $80 at Wedbush
WDAY Workday
$167.70 /

+24.325 (+16.97%)

11/30/22 Deutsche Bank
Workday price target lowered to $215 from $230 at Deutsche Bank
11/30/22 Baird
Workday price target lowered to $223 from $235 at Baird
11/30/22 JPMorgan
Workday price target lowered to $223 from $235 at JPMorgan
11/30/22 Mizuho
Workday price target lowered to $200 from $220 at Mizuho
LESL Leslie's
$14.61 /

-0.475 (-3.15%)

12/01/22 Stifel
Leslie's downgraded to Hold from Buy at Stifel
11/28/22 Stifel
Leslie's price target lowered to $17 from $20 at Stifel
11/15/22 Baird
Leslie's downgraded to Neutral from Outperform at Baird
10/03/22 MKM Partners
MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
WOOF Petco
$11.06 /

+1.585 (+16.73%)

12/01/22 UBS
Petco price target lowered to $12 from $16 at UBS
11/30/22 Baird
Petco price target lowered to $14 from $18 at Baird
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/28/22 Needham
Petco price target lowered to $20 from $30 at Needham
CRL Charles River
$228.53 /

-10.91 (-4.56%)

11/30/22 Wells Fargo
Bust of smuggling ring likely to beheadwind for LabCorp, says Wells Fargo
11/03/22 Credit Suisse
Charles River price target lowered to $280 from $285 at Credit Suisse
09/30/22 Jefferies
Charles River upgraded to Buy at Jefferies on nonhuman primate tailwinds
09/29/22 Jefferies
Charles River upgraded to Buy from Hold at Jefferies
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

WOOF Petco
$11.06 /

+1.585 (+16.73%)

WDAY Workday
$167.70 /

+24.325 (+16.97%)

UNP Union Pacific
$217.49 /

+4.625 (+2.17%)

UBS UBS
$18.44 /

+0.185 (+1.01%)

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

SLDP Solid Power
$3.66 /

-0.62 (-14.49%)

RIVN Rivian Automotive
$32.05 /

+3.195 (+11.07%)

PINS Pinterest
$25.40 /

+1.395 (+5.81%)

NTR Nutrien
$80.44 /

-1.17 (-1.43%)

NTAP NetApp
$67.59 /

-4.195 (-5.84%)

NSC Norfolk Southern
$256.40 /

+3.09 (+1.22%)

LESL Leslie's
$14.61 /

-0.475 (-3.15%)

LCID Lucid Group
$10.12 /

+0.355 (+3.64%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

INTU Intuit
$407.32 /

+26.2 (+6.87%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

HRL Hormel Foods
$46.99 /

-1.175 (-2.44%)

HPE HP Enterprise
$16.79 /

+1.325 (+8.57%)

FSR Fisker
$7.73 /

+0.455 (+6.25%)

CVNA Carvana
$7.69 /

+0.355 (+4.84%)

CSX CSX
$32.71 /

+0.53 (+1.65%)

CRWD Crowdstrike
$117.56 /

-20.62 (-14.92%)

CRL Charles River
$228.53 /

-10.91 (-4.56%)

CP Canadian Pacific
$81.93 /

+1.615 (+2.01%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

CNI Canadian National
$128.40 /

+3.2 (+2.56%)

BIDU Baidu
$108.65 /

+8.93 (+8.96%)

ASTS AST SpaceMobile
$5.77 /

-0.58 (-9.13%)

AREC American Resources
$1.51 /

-0.16 (-9.61%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

ABNB Airbnb
$102.20 /

+6.8 (+7.13%)

$ECON Economic Data
/

+

  • 30
    Nov
  • 22
    Apr
  • 15
    Dec
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

UBS UBS
$18.44 /

+0.185 (+1.01%)

SPX S&P 500
/

+

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

RIVN Rivian Automotive
$32.05 /

+3.195 (+11.07%)

PINS Pinterest
$25.40 /

+1.395 (+5.81%)

LCID Lucid Group
$10.12 /

+0.355 (+3.64%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

INTU Intuit
$407.32 /

+26.2 (+6.87%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

HRL Hormel Foods
$46.99 /

-1.175 (-2.44%)

FSR Fisker
$7.73 /

+0.455 (+6.25%)

CVNA Carvana
$7.69 /

+0.355 (+4.84%)

CRWD Crowdstrike
$117.56 /

-20.62 (-14.92%)

CNI Canadian National
$128.40 /

+3.2 (+2.56%)

BIDU Baidu
$108.65 /

+8.93 (+8.96%)

ASTS AST SpaceMobile
$5.77 /

-0.58 (-9.13%)

AREC American Resources
$1.51 /

-0.16 (-9.61%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

ABNB Airbnb
$102.20 /

+6.8 (+7.13%)

$ECON Economic Data
/

+

WOOF Petco
$11.06 /

+1.585 (+16.73%)

UNP Union Pacific
$217.49 /

+4.625 (+2.17%)

UBS UBS
$18.44 /

+0.185 (+1.01%)

SPX S&P 500
/

+

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

RIVN Rivian Automotive
$32.05 /

+3.195 (+11.07%)

PINS Pinterest
$25.40 /

+1.395 (+5.81%)

NTR Nutrien
$80.44 /

-1.17 (-1.43%)

NTAP NetApp
$67.59 /

-4.195 (-5.84%)

NSC Norfolk Southern
$256.40 /

+3.09 (+1.22%)

LCID Lucid Group
$10.12 /

+0.355 (+3.64%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

INTU Intuit
$407.32 /

+26.2 (+6.87%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

HRL Hormel Foods
$46.99 /

-1.175 (-2.44%)

HPE HP Enterprise
$16.79 /

+1.325 (+8.57%)

FSR Fisker
$7.73 /

+0.455 (+6.25%)

CVNA Carvana
$7.69 /

+0.355 (+4.84%)

CSX CSX
$32.71 /

+0.53 (+1.65%)

CRWD Crowdstrike
$117.56 /

-20.62 (-14.92%)

CRL Charles River
$228.53 /

-10.91 (-4.56%)

CP Canadian Pacific
$81.93 /

+1.615 (+2.01%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

CNI Canadian National
$128.40 /

+3.2 (+2.56%)

BIDU Baidu
$108.65 /

+8.93 (+8.96%)

ASTS AST SpaceMobile
$5.77 /

-0.58 (-9.13%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

ABNB Airbnb
$102.20 /

+6.8 (+7.13%)

$ECON Economic Data
/

+

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

WDAY Workday
$167.70 /

+24.325 (+16.97%)

UNP Union Pacific
$217.49 /

+4.625 (+2.17%)

UBS UBS
$18.44 /

+0.185 (+1.01%)

SPX S&P 500
/

+

SNY Sanofi
$45.35 /

-0.535 (-1.17%)

RIVN Rivian Automotive
$32.05 /

+3.195 (+11.07%)

PINS Pinterest
$25.40 /

+1.395 (+5.81%)

NTR Nutrien
$80.44 /

-1.17 (-1.43%)

NTAP NetApp
$67.59 /

-4.195 (-5.84%)

LESL Leslie's
$14.61 /

-0.475 (-3.15%)

LCID Lucid Group
$10.12 /

+0.355 (+3.64%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

INTU Intuit
$407.32 /

+26.2 (+6.87%)

HZNP Horizon Therapeutics
$100.26 /

+21.51 (+27.31%)

HPE HP Enterprise
$16.79 /

+1.325 (+8.57%)

FSR Fisker
$7.73 /

+0.455 (+6.25%)

CVNA Carvana
$7.69 /

+0.355 (+4.84%)

CSX CSX
$32.71 /

+0.53 (+1.65%)

CRWD Crowdstrike
$117.56 /

-20.62 (-14.92%)

CRL Charles River
$228.53 /

-10.91 (-4.56%)

BIDU Baidu
$108.65 /

+8.93 (+8.96%)

ASTS AST SpaceMobile
$5.77 /

-0.58 (-9.13%)

AREC American Resources
$1.51 /

-0.16 (-9.61%)

AMGN Amgen
$286.51 /

+4.49 (+1.59%)

ABNB Airbnb
$102.20 /

+6.8 (+7.13%)

SPY SPDR S&P 500 ETF Trust
$407.47 /

+12.2 (+3.09%)

On The Fly
What You Missed On Wall Street This Morning » 12:17
11/30/22
11/30
12:17
11/30/22
12:17
CRWD

Crowdstrike

$111.07 /

-27.11 (-19.62%)

, FSR

Fisker

$7.47 /

+0.195 (+2.68%)

, RIVN

Rivian Automotive

$30.07 /

+1.215 (+4.21%)

, LCID

Lucid Group

$9.91 /

+0.15 (+1.54%)

, HPE

HP Enterprise

$16.06 /

+0.595 (+3.85%)

, HZNP

Horizon Therapeutics

$99.90 /

+21.15 (+26.86%)

, AMGN

Amgen

$280.33 /

-1.69 (-0.60%)

, JNJ

Johnson & Johnson

$175.49 /

-0.55 (-0.31%)

, SNY

Sanofi

$44.76 /

-1.125 (-2.45%)

, INTU

Intuit

$394.43 /

+13.31 (+3.49%)

, HRL

Hormel Foods

$46.13 /

-2.035 (-4.23%)

, AREC

American Resources

$1.51 /

-0.155 (-9.31%)

, UBS

UBS

$18.11 /

-0.145 (-0.79%)

, AAPL

Apple

$141.49 /

+0.3 (+0.21%)

, TWTR

Twitter

$53.71 /

+ (+0.00%)

, ABNB

Airbnb

$96.74 /

+1.335 (+1.40%)

, PINS

Pinterest

$24.49 /

+0.48 (+2.00%)

, XPEV

XPeng

$10.44 /

+3.09 (+42.04%)

, BIDU

Baidu

$106.53 /

+6.81 (+6.83%)

, SLDP

Solid Power

$3.23 /

-1.055 (-24.65%)

, ASTS

AST SpaceMobile

$5.66 /

-0.695 (-10.94%)

, MU

Micron

$54.59 /

-0.54 (-0.98%)

, NTAP

NetApp

$65.43 /

-6.35 (-8.85%)

, WDAY

Workday

$160.55 /

+17.18 (+11.98%)

, LESL

Leslie's

$13.65 /

-1.43 (-9.48%)

, WOOF

Petco

$10.72 /

+1.245 (+13.14%)

, BBW

Build-A-Bear

$22.31 /

+2.95 (+15.24%)

, COO

Cooper Companies

$311.12 /

+3.84 (+1.25%)

, CVNA

Carvana

$7.02 /

-0.315 (-4.30%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$10.44 /

+3.09 (+42.04%)

WOOF Petco
$10.72 /

+1.245 (+13.14%)

WDAY Workday
$160.55 /

+17.18 (+11.98%)

UBS UBS
$18.11 /

-0.145 (-0.79%)

TWTR Twitter
$53.71 /

+ (+0.00%)

SNY Sanofi
$44.76 /

-1.125 (-2.45%)

SLDP Solid Power
$3.23 /

-1.055 (-24.65%)

RIVN Rivian Automotive
$30.07 /

+1.215 (+4.21%)

PINS Pinterest
$24.49 /

+0.48 (+2.00%)

NTAP NetApp
$65.43 /

-6.35 (-8.85%)

MU Micron
$54.59 /

-0.54 (-0.98%)

LESL Leslie's
$13.65 /

-1.43 (-9.48%)

LCID Lucid Group
$9.91 /

+0.15 (+1.54%)

JNJ Johnson & Johnson
$175.49 /

-0.55 (-0.31%)

INTU Intuit
$394.43 /

+13.31 (+3.49%)

HZNP Horizon Therapeutics
$99.90 /

+21.15 (+26.86%)

HRL Hormel Foods
$46.13 /

-2.035 (-4.23%)

HPE HP Enterprise
$16.06 /

+0.595 (+3.85%)

FSR Fisker
$7.47 /

+0.195 (+2.68%)

CVNA Carvana
$7.02 /

-0.315 (-4.30%)

CRWD Crowdstrike
$111.07 /

-27.11 (-19.62%)

COO Cooper Companies
$311.12 /

+3.84 (+1.25%)

BIDU Baidu
$106.53 /

+6.81 (+6.83%)

BBW Build-A-Bear
$22.31 /

+2.95 (+15.24%)

ASTS AST SpaceMobile
$5.66 /

-0.695 (-10.94%)

AREC American Resources
$1.51 /

-0.155 (-9.31%)

AMGN Amgen
$280.33 /

-1.69 (-0.60%)

ABNB Airbnb
$96.74 /

+1.335 (+1.40%)

AAPL Apple
$141.49 /

+0.3 (+0.21%)

CRWD Crowdstrike
$111.07 /

-27.11 (-19.62%)

11/30/22 Truist
Crowdstrike price target lowered to $200 from $275 at Truist
11/30/22 RBC Capital
Crowdstrike price target lowered to $165 from $200 at RBC Capital
11/30/22 Needham
Crowdstrike price target lowered to $165 from $225 at Needham
11/30/22 DA Davidson
Crowdstrike price target lowered to $145 from $235 at DA Davidson
FSR Fisker
$7.47 /

+0.195 (+2.68%)

11/29/22 Evercore ISI
Fisker initiated with an Outperform, $15 price target at Evercore ISI
11/29/22 Evercore ISI
Fisker initiated with an Outperform at Evercore ISI
11/03/22 RBC Capital
Fisker cut to Sector Perform at RBC Capital amid growing execution risk
11/03/22 RBC Capital
Fisker downgraded to Sector Perform from Outperform at RBC Capital
RIVN Rivian Automotive
$30.07 /

+1.215 (+4.21%)

11/29/22 Evercore ISI
Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
11/29/22 Evercore ISI
Rivian Automotive initiated with an In Line at Evercore ISI
11/10/22 RBC Capital
Rivian Automotive price target lowered to $50 from $61 at RBC Capital
11/10/22 Deutsche Bank
Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
LCID Lucid Group
$9.91 /

+0.15 (+1.54%)

11/29/22 Evercore ISI
Lucid Group initiated with an In Line, $12 price target at Evercore ISI
11/29/22 Evercore ISI
Lucid Group initiated with an In Line at Evercore ISI
11/10/22 R.F. Lafferty
Lucid Group price target lowered to $17 from $19 at R.F. Lafferty
09/27/22 Cantor Fitzgerald
Lucid Group initiated with an Overweight at Cantor Fitzgerald
HPE HP Enterprise
$16.06 /

+0.595 (+3.85%)

11/30/22 Susquehanna
HP Enterprise price target raised to $16 from $15 at Susquehanna
11/30/22 Deutsche Bank
HP Enterprise price target raised to $16 from $15 at Deutsche Bank
11/30/22 Morgan Stanley
HP Enterprise price target raised to $13 from $12 at Morgan Stanley
11/30/22 Citi
HP Enterprise price target raised to $13 from $11.50 at Citi
HZNP Horizon Therapeutics
$99.90 /

+21.15 (+26.86%)

11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
10/25/22 Piper Sandler
Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
AMGN Amgen
$280.33 /

-1.69 (-0.60%)

11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
11/08/22 Oppenheimer
Amgen price target raised to $300 from $290 at Oppenheimer
11/08/22 Truist
Amgen price target raised to $280 from $266 at Truist
JNJ Johnson & Johnson
$175.49 /

-0.55 (-0.31%)

11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
SNY Sanofi
$44.76 /

-1.125 (-2.45%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
INTU Intuit
$394.43 /

+13.31 (+3.49%)

11/30/22 Oppenheimer
Intuit price target lowered to $476 from $516 at Oppenheimer
11/30/22 Wells Fargo
Intuit price target lowered to $475 from $525 at Wells Fargo
11/30/22 Deutsche Bank
Intuit price target lowered to $525 from $560 at Deutsche Bank
11/30/22 BofA
Intuit price target lowered to $475 from $500 at BofA
HRL Hormel Foods
$46.13 /

-2.035 (-4.23%)

09/22/22 Argus
Hormel Foods price target lowered to $53 from $54 at Argus
09/02/22 Piper Sandler
Hormel Foods price target lowered to $47 from $48 at Piper Sandler
08/23/22 Stephens
Hormel Foods price target raised to $55 from $50 at Stephens
03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
AREC American Resources
$1.51 /

-0.155 (-9.31%)

UBS UBS
$18.11 /

-0.145 (-0.79%)

10/26/22 JPMorgan
UBS price target raised to CHF 20.70 from CHF 20 at JPMorgan
10/26/22 Deutsche Bank
UBS price target raised to CHF 22 from CHF 21 at Deutsche Bank
10/26/22 RBC Capital
UBS price target raised to CHF 20 from CHF 19 at RBC Capital
10/26/22 Morgan Stanley
UBS price target raised to CHF 20 from CHF 18.50 at Morgan Stanley
AAPL Apple
$141.49 /

+0.3 (+0.21%)

11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
11/30/22 Baird
Apple estimates lowered due to ongoing assembly challenges, says Baird
11/29/22 Deutsche Bank
Apple Pay taking e-commerce share from PayPal, says Deutsche Bank
11/28/22 Wedbush
Apple iPhone shortages build into holiday season, says Wedbush
TWTR Twitter
$53.71 /

+ (+0.00%)

11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
10/31/22 Gordon Haskett
Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
10/21/22 Wedbush
Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
10/18/22 Gordon Haskett
Bilson sees Tesla share sale coming with Musk $8B short for Twitter
ABNB Airbnb
$96.74 /

+1.335 (+1.40%)

11/22/22 Barclays
Airbnb price target raised to $103 from $101 at Barclays
11/22/22 Baird
Airbnb downgraded to Neutral from Outperform at Baird
11/17/22 Citi
Airbnb supply growth should continue to ramp, says Citi
11/02/22 Evercore ISI
Airbnb removed for 'TAP Outperform' list at Evercore ISI
PINS Pinterest
$24.49 /

+0.48 (+2.00%)

10/31/22 Citi
Pinterest price target raised to $26 from $25 at Citi
10/28/22 Stifel
Pinterest 'a rare bright spot thus far through earnings,' says Stifel
10/28/22 Barclays
Pinterest price target raised to $25 from $23 at Barclays
10/28/22 Piper Sandler
Pinterest price target raised to $25 from $23 at Piper Sandler
XPEV XPeng
$10.44 /

+3.09 (+42.04%)

11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/28/22 Jefferies
XPeng downgraded to Underperform from Hold at Jefferies
11/22/22 DBS Bank
XPeng initiated with a Buy at DBS Bank (earlier)
11/17/22 UBS
XPeng upgraded to Buy from Neutral at UBS
BIDU Baidu
$106.53 /

+6.81 (+6.83%)

11/23/22 Morgan Stanley
Baidu price target lowered to $120 from $140 at Morgan Stanley
11/23/22 Benchmark
Baidu price target lowered to $200 from $270 at Benchmark
11/23/22 Mizuho
Baidu price target lowered to $180 from $200 at Mizuho
11/23/22 Citi
Baidu price target lowered to $166 from $169 at Citi
SLDP Solid Power
$3.23 /

-1.055 (-24.65%)

11/30/22 DA Davidson
Solid Power cut to Neutral at DA Davidson on sudden announcement of CEO retiring
11/30/22 DA Davidson
Solid Power downgraded to Neutral from Buy at DA Davidson
10/31/22 Cowen
Solid Power initiated with a Market Perform at Cowen
06/29/22 Chardan
Solid Power initiated with a Buy at Chardan
ASTS AST SpaceMobile
$5.66 /

-0.695 (-10.94%)

11/23/22 Deutsche Bank
AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
10/28/22 B. Riley
AST SpaceMobile initiated with a Buy at B. Riley
10/19/22 Barclays
AST SpaceMobile price target lowered to $15 from $29 at Barclays
08/17/22 Deutsche Bank
AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
MU Micron
$54.59 /

-0.54 (-0.98%)

11/30/22 Stifel
Micron management's tone 'incrementally downbeat,' says Stifel
11/29/22 Mizuho
Micron price target lowered to $50 from $52 at Mizuho
11/17/22 UBS
Micron price target lowered to $75 from $80 at UBS
11/16/22 Wedbush
Wedbush keeps Outperform on Micron, says deterioration understood
NTAP NetApp
$65.43 /

-6.35 (-8.85%)

11/30/22 Northland
NetApp price target lowered to $99 from $101 at Northland
11/30/22 Wells Fargo
NetApp price target lowered to $70 from $85 at Wells Fargo
11/30/22 Cowen
NetApp price target lowered to $80 from $93 at Cowen
11/30/22 Wedbush
NetApp price target lowered to $70 from $80 at Wedbush
WDAY Workday
$160.55 /

+17.18 (+11.98%)

11/30/22 Deutsche Bank
Workday price target lowered to $215 from $230 at Deutsche Bank
11/30/22 Baird
Workday price target lowered to $223 from $235 at Baird
11/30/22 JPMorgan
Workday price target lowered to $223 from $235 at JPMorgan
11/30/22 Mizuho
Workday price target lowered to $200 from $220 at Mizuho
LESL Leslie's
$13.65 /

-1.43 (-9.48%)

11/28/22 Stifel
Leslie's price target lowered to $17 from $20 at Stifel
11/15/22 Baird
Leslie's downgraded to Neutral from Outperform at Baird
10/03/22 MKM Partners
MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
10/03/22 MKM Partners
Leslie's initiated with a Neutral at MKM Partners
WOOF Petco
$10.72 /

+1.245 (+13.14%)

11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/28/22 Needham
Petco price target lowered to $20 from $30 at Needham
10/31/22 Citi
Petco price target lowered to $15 from $19 at Citi
10/21/22 Jefferies
Petco transferred with a Hold at Jefferies
BBW Build-A-Bear
$22.31 /

+2.95 (+15.24%)

COO Cooper Companies
$311.12 /

+3.84 (+1.25%)

11/30/22 Baird
Cooper Companies upgraded to Outperform from Neutral at Baird
11/28/22 JPMorgan
Cooper Companies price target raised to $330 from $300 at JPMorgan
11/03/22 Piper Sandler
Cooper Companies price target lowered to $355 from $375 at Piper Sandler
10/11/22 Jefferies
Cooper Companies downgraded to Hold from Buy at Jefferies
CVNA Carvana
$7.02 /

-0.315 (-4.30%)

11/30/22 BofA
BofA downgrades Carvana to Neutral on liquidity concerns
11/30/22 BofA
Carvana downgraded to Neutral from Buy at BofA
11/22/22 Baird
Carvana downgraded to Neutral from Outperform at Baird
11/21/22 Cowen
Carvana downgraded to Market Perform from Outperform at Cowen
XPEV XPeng
$10.44 /

+3.09 (+42.04%)

WOOF Petco
$10.72 /

+1.245 (+13.14%)

WDAY Workday
$160.55 /

+17.18 (+11.98%)

UBS UBS
$18.11 /

-0.145 (-0.79%)

TWTR Twitter
$53.71 /

+ (+0.00%)

SNY Sanofi
$44.76 /

-1.125 (-2.45%)

SLDP Solid Power
$3.23 /

-1.055 (-24.65%)

RIVN Rivian Automotive
$30.07 /

+1.215 (+4.21%)

PINS Pinterest
$24.49 /

+0.48 (+2.00%)

NTAP NetApp
$65.43 /

-6.35 (-8.85%)

MU Micron
$54.59 /

-0.54 (-0.98%)

LESL Leslie's
$13.65 /

-1.43 (-9.48%)

LCID Lucid Group
$9.91 /

+0.15 (+1.54%)

JNJ Johnson & Johnson
$175.49 /

-0.55 (-0.31%)

INTU Intuit
$394.43 /

+13.31 (+3.49%)

HZNP Horizon Therapeutics
$99.90 /

+21.15 (+26.86%)

HRL Hormel Foods
$46.13 /

-2.035 (-4.23%)

HPE HP Enterprise
$16.06 /

+0.595 (+3.85%)

FSR Fisker
$7.47 /

+0.195 (+2.68%)

CVNA Carvana
$7.02 /

-0.315 (-4.30%)

CRWD Crowdstrike
$111.07 /

-27.11 (-19.62%)

COO Cooper Companies
$311.12 /

+3.84 (+1.25%)

BIDU Baidu
$106.53 /

+6.81 (+6.83%)

BBW Build-A-Bear
$22.31 /

+2.95 (+15.24%)

ASTS AST SpaceMobile
$5.66 /

-0.695 (-10.94%)

AREC American Resources
$1.51 /

-0.155 (-9.31%)

AMGN Amgen
$280.33 /

-1.69 (-0.60%)

ABNB Airbnb
$96.74 /

+1.335 (+1.40%)

AAPL Apple
$141.49 /

+0.3 (+0.21%)

  • 30
    Nov
  • 22
    Apr
  • 15
    Dec
XPEV XPeng
$10.44 /

+3.09 (+42.04%)

UBS UBS
$18.11 /

-0.145 (-0.79%)

TWTR Twitter
$53.71 /

+ (+0.00%)

SNY Sanofi
$44.76 /

-1.125 (-2.45%)

RIVN Rivian Automotive
$30.07 /

+1.215 (+4.21%)

PINS Pinterest
$24.49 /

+0.48 (+2.00%)

MU Micron
$54.59 /

-0.54 (-0.98%)

LCID Lucid Group
$9.91 /

+0.15 (+1.54%)

JNJ Johnson & Johnson
$175.49 /

-0.55 (-0.31%)

INTU Intuit
$394.43 /

+13.31 (+3.49%)

HZNP Horizon Therapeutics
$99.90 /

+21.15 (+26.86%)

HRL Hormel Foods
$46.13 /

-2.035 (-4.23%)

FSR Fisker
$7.47 /

+0.195 (+2.68%)

CVNA Carvana
$7.02 /

-0.315 (-4.30%)

CRWD Crowdstrike
$111.07 /

-27.11 (-19.62%)

BIDU Baidu
$106.53 /

+6.81 (+6.83%)

ASTS AST SpaceMobile
$5.66 /

-0.695 (-10.94%)

AREC American Resources
$1.51 /

-0.155 (-9.31%)

AMGN Amgen
$280.33 /

-1.69 (-0.60%)

ABNB Airbnb
$96.74 /

+1.335 (+1.40%)

AAPL Apple
$141.49 /

+0.3 (+0.21%)

XPEV XPeng
$10.44 /

+3.09 (+42.04%)

WOOF Petco
$10.72 /

+1.245 (+13.14%)

WDAY Workday
$160.55 /

+17.18 (+11.98%)

UBS UBS
$18.11 /

-0.145 (-0.79%)

TWTR Twitter
$53.71 /

+ (+0.00%)

SNY Sanofi
$44.76 /

-1.125 (-2.45%)

RIVN Rivian Automotive
$30.07 /

+1.215 (+4.21%)

PINS Pinterest
$24.49 /

+0.48 (+2.00%)

NTAP NetApp
$65.43 /

-6.35 (-8.85%)

MU Micron
$54.59 /

-0.54 (-0.98%)

LCID Lucid Group
$9.91 /

+0.15 (+1.54%)

INTU Intuit
$394.43 /

+13.31 (+3.49%)

HZNP Horizon Therapeutics
$99.90 /

+21.15 (+26.86%)

HRL Hormel Foods
$46.13 /

-2.035 (-4.23%)

HPE HP Enterprise
$16.06 /

+0.595 (+3.85%)

FSR Fisker
$7.47 /

+0.195 (+2.68%)

CVNA Carvana
$7.02 /

-0.315 (-4.30%)

CRWD Crowdstrike
$111.07 /

-27.11 (-19.62%)

COO Cooper Companies
$311.12 /

+3.84 (+1.25%)

BIDU Baidu
$106.53 /

+6.81 (+6.83%)

ASTS AST SpaceMobile
$5.66 /

-0.695 (-10.94%)

AMGN Amgen
$280.33 /

-1.69 (-0.60%)

ABNB Airbnb
$96.74 /

+1.335 (+1.40%)

AAPL Apple
$141.49 /

+0.3 (+0.21%)

XPEV XPeng
$10.44 /

+3.09 (+42.04%)

WDAY Workday
$160.55 /

+17.18 (+11.98%)

UBS UBS
$18.11 /

-0.145 (-0.79%)

TWTR Twitter
$53.71 /

+ (+0.00%)

SNY Sanofi
$44.76 /

-1.125 (-2.45%)

RIVN Rivian Automotive
$30.07 /

+1.215 (+4.21%)

PINS Pinterest
$24.49 /

+0.48 (+2.00%)

NTAP NetApp
$65.43 /

-6.35 (-8.85%)

MU Micron
$54.59 /

-0.54 (-0.98%)

LESL Leslie's
$13.65 /

-1.43 (-9.48%)

LCID Lucid Group
$9.91 /

+0.15 (+1.54%)

JNJ Johnson & Johnson
$175.49 /

-0.55 (-0.31%)

INTU Intuit
$394.43 /

+13.31 (+3.49%)

HZNP Horizon Therapeutics
$99.90 /

+21.15 (+26.86%)

HPE HP Enterprise
$16.06 /

+0.595 (+3.85%)

FSR Fisker
$7.47 /

+0.195 (+2.68%)

CVNA Carvana
$7.02 /

-0.315 (-4.30%)

CRWD Crowdstrike
$111.07 /

-27.11 (-19.62%)

BIDU Baidu
$106.53 /

+6.81 (+6.83%)

ASTS AST SpaceMobile
$5.66 /

-0.695 (-10.94%)

AREC American Resources
$1.51 /

-0.155 (-9.31%)

AMGN Amgen
$280.33 /

-1.69 (-0.60%)

ABNB Airbnb
$96.74 /

+1.335 (+1.40%)

AAPL Apple
$141.49 /

+0.3 (+0.21%)

On The Fly
Fly Intel: Pre-market Movers » 09:00
11/30/22
11/30
09:00
11/30/22
09:00
BIIB

Biogen

$291.47 /

-0.49 (-0.17%)

, HZNP

Horizon Therapeutics

$78.78 /

+0.69 (+0.88%)

, WOOF

Petco

$9.48 /

-0.185 (-1.92%)

, TITN

Titan Machinery

$34.89 /

-0.52 (-1.47%)

, DCI

Donaldson

$59.28 /

-0.44 (-0.74%)

, ENB

Enbridge

$40.86 /

-0.34 (-0.83%)

, BBW

Build-A-Bear

$19.36 /

+0.54 (+2.87%)

, XPEV

XPeng

$7.35 /

+0.44 (+6.37%)

, WDAY

Workday

$143.37 /

-1.98 (-1.36%)

, LESL

Leslie's

$15.07 /

+0.47 (+3.22%)

, HRL

Hormel Foods

$48.17 /

-0.945 (-1.92%)

, CRWD

Crowdstrike

$137.99 /

-1.6 (-1.15%)

, ASTS

AST SpaceMobile

$6.35 /

-0.01 (-0.16%)

, JNJ

Johnson & Johnson

$176.04 /

-1.26 (-0.71%)

, AMGN

Amgen

$282.00 /

-0.67 (-0.24%)

, SNY

Sanofi

$45.89 /

+0.33 (+0.72%)

, ESALY

Eisai

$64.75 /

-0.35 (-0.54%)

Check out this morning's…

ShowHide Related Items >><<
XPEV XPeng
$7.35 /

+0.44 (+6.37%)

WOOF Petco
$9.48 /

-0.185 (-1.92%)

WDAY Workday
$143.37 /

-1.98 (-1.36%)

TITN Titan Machinery
$34.89 /

-0.52 (-1.47%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

LESL Leslie's
$15.07 /

+0.47 (+3.22%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

HRL Hormel Foods
$48.17 /

-0.945 (-1.92%)

ESALY Eisai
$64.75 /

-0.35 (-0.54%)

ENB Enbridge
$40.86 /

-0.34 (-0.83%)

DCI Donaldson
$59.28 /

-0.44 (-0.74%)

CRWD Crowdstrike
$137.99 /

-1.6 (-1.15%)

BIIB Biogen
$291.47 /

-0.49 (-0.17%)

BBW Build-A-Bear
$19.36 /

+0.54 (+2.87%)

ASTS AST SpaceMobile
$6.35 /

-0.01 (-0.16%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

BIIB Biogen
$291.47 /

-0.49 (-0.17%)

11/30/22 Mizuho
Mizuho says Biogen not mentioned in 90 minute lecanemab presentation
11/30/22 Jefferies
Biogen price target raised to $350 from $325 at Jefferies
11/30/22 Wedbush
Biogen price target raised to $247 from $218 at Wedbush
11/30/22 JPMorgan
Biogen Alzheimer's data increases approval confidence, says JPMorgan
HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
10/25/22 Piper Sandler
Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
WOOF Petco
$9.48 /

-0.185 (-1.92%)

11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/28/22 Needham
Petco price target lowered to $20 from $30 at Needham
10/31/22 Citi
Petco price target lowered to $15 from $19 at Citi
10/21/22 Jefferies
Petco transferred with a Hold at Jefferies
TITN Titan Machinery
$34.89 /

-0.52 (-1.47%)

08/25/22 Baird
Titan Machinery price target raised to $34 from $27 at Baird
07/11/22 Baird
Baird trims Titan Machinery price target to $27, but 'likes' Heartland Ag deal
05/27/22 Stephens
Titan Machinery price target lowered to $41 from $44 at Stephens
05/26/22 Baird
Titan Machinery price target raised to $32 from $30 at Baird
DCI Donaldson
$59.28 /

-0.44 (-0.74%)

09/01/22 Baird
Donaldson price target lowered to $59 from $61 at Baird
07/18/22 Stifel
Donaldson price target lowered to $51 from $53 at Stifel
06/02/22 Baird
Donaldson price target lowered to $61 from $65 at Baird
03/03/22 Baird
Donaldson price target lowered to $65 from $70 at Baird
ENB Enbridge
$40.86 /

-0.34 (-0.83%)

11/07/22 National Bank
Enbridge downgraded to Sector Perform from Outperform at National Bank
10/20/22 Scotiabank
Enbridge price target lowered to C$56 from C$62 at Scotiabank
10/19/22 Morgan Stanley
Enbridge price target lowered to C$64 from C$67 at Morgan Stanley
09/12/22 Raymond James
Enbridge upgraded to Outperform from Market Perform at Raymond James
BBW Build-A-Bear
$19.36 /

+0.54 (+2.87%)

XPEV XPeng
$7.35 /

+0.44 (+6.37%)

11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/28/22 Jefferies
XPeng downgraded to Underperform from Hold at Jefferies
11/22/22 DBS Bank
XPeng initiated with a Buy at DBS Bank (earlier)
11/17/22 UBS
XPeng upgraded to Buy from Neutral at UBS
WDAY Workday
$143.37 /

-1.98 (-1.36%)

11/30/22 Deutsche Bank
Workday price target lowered to $215 from $230 at Deutsche Bank
11/30/22 Baird
Workday price target lowered to $223 from $235 at Baird
11/30/22 JPMorgan
Workday price target lowered to $223 from $235 at JPMorgan
11/30/22 Mizuho
Workday price target lowered to $200 from $220 at Mizuho
LESL Leslie's
$15.07 /

+0.47 (+3.22%)

11/28/22 Stifel
Leslie's price target lowered to $17 from $20 at Stifel
11/15/22 Baird
Leslie's downgraded to Neutral from Outperform at Baird
10/03/22 MKM Partners
MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
10/03/22 MKM Partners
Leslie's initiated with a Neutral at MKM Partners
HRL Hormel Foods
$48.17 /

-0.945 (-1.92%)

09/22/22 Argus
Hormel Foods price target lowered to $53 from $54 at Argus
09/02/22 Piper Sandler
Hormel Foods price target lowered to $47 from $48 at Piper Sandler
08/23/22 Stephens
Hormel Foods price target raised to $55 from $50 at Stephens
03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
CRWD Crowdstrike
$137.99 /

-1.6 (-1.15%)

11/30/22 Needham
Crowdstrike price target lowered to $165 from $225 at Needham
11/30/22 DA Davidson
Crowdstrike price target lowered to $145 from $235 at DA Davidson
11/30/22 MKM Partners
Crowdstrike price target lowered to $190 from $200 at MKM Partners
11/30/22 Morgan Stanley
Morgan Stanley says investors should 'buy the dip' in Crowdstrike after Q3
ASTS AST SpaceMobile
$6.35 /

-0.01 (-0.16%)

11/23/22 Deutsche Bank
AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
10/28/22 B. Riley
AST SpaceMobile initiated with a Buy at B. Riley
10/19/22 Barclays
AST SpaceMobile price target lowered to $15 from $29 at Barclays
08/17/22 Deutsche Bank
AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
AMGN Amgen
$282.00 /

-0.67 (-0.24%)

11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
11/08/22 Oppenheimer
Amgen price target raised to $300 from $290 at Oppenheimer
11/08/22 Truist
Amgen price target raised to $280 from $266 at Truist
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
ESALY Eisai
$64.75 /

-0.35 (-0.54%)

11/29/22 Jefferies
Prothena data from AD/PD abstract 'promising,' says Jefferies
11/14/22 Jefferies
Biogen scarcity value goes up after Roche miss in Alzheimer's, says Jefferies
XPEV XPeng
$7.35 /

+0.44 (+6.37%)

WOOF Petco
$9.48 /

-0.185 (-1.92%)

WDAY Workday
$143.37 /

-1.98 (-1.36%)

TITN Titan Machinery
$34.89 /

-0.52 (-1.47%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

LESL Leslie's
$15.07 /

+0.47 (+3.22%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

HRL Hormel Foods
$48.17 /

-0.945 (-1.92%)

ENB Enbridge
$40.86 /

-0.34 (-0.83%)

DCI Donaldson
$59.28 /

-0.44 (-0.74%)

CRWD Crowdstrike
$137.99 /

-1.6 (-1.15%)

BIIB Biogen
$291.47 /

-0.49 (-0.17%)

BBW Build-A-Bear
$19.36 /

+0.54 (+2.87%)

ASTS AST SpaceMobile
$6.35 /

-0.01 (-0.16%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

  • 30
    Nov
  • 15
    Dec
XPEV XPeng
$7.35 /

+0.44 (+6.37%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

HRL Hormel Foods
$48.17 /

-0.945 (-1.92%)

ENB Enbridge
$40.86 /

-0.34 (-0.83%)

CRWD Crowdstrike
$137.99 /

-1.6 (-1.15%)

BIIB Biogen
$291.47 /

-0.49 (-0.17%)

ASTS AST SpaceMobile
$6.35 /

-0.01 (-0.16%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

XPEV XPeng
$7.35 /

+0.44 (+6.37%)

WOOF Petco
$9.48 /

-0.185 (-1.92%)

WDAY Workday
$143.37 /

-1.98 (-1.36%)

TITN Titan Machinery
$34.89 /

-0.52 (-1.47%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

HRL Hormel Foods
$48.17 /

-0.945 (-1.92%)

ESALY Eisai
$64.75 /

-0.35 (-0.54%)

CRWD Crowdstrike
$137.99 /

-1.6 (-1.15%)

BIIB Biogen
$291.47 /

-0.49 (-0.17%)

ASTS AST SpaceMobile
$6.35 /

-0.01 (-0.16%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

XPEV XPeng
$7.35 /

+0.44 (+6.37%)

WDAY Workday
$143.37 /

-1.98 (-1.36%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

LESL Leslie's
$15.07 /

+0.47 (+3.22%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

ENB Enbridge
$40.86 /

-0.34 (-0.83%)

CRWD Crowdstrike
$137.99 /

-1.6 (-1.15%)

BIIB Biogen
$291.47 /

-0.49 (-0.17%)

ASTS AST SpaceMobile
$6.35 /

-0.01 (-0.16%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

Hot Stocks
Regeneron: FDA accepts for Priority Review sBLA for Evkeeza » 08:06
11/30/22
11/30
08:06
11/30/22
08:06
REGN

Regeneron

$736.08 /

-5.545 (-0.75%)

Regeneron Pharmaceuticals…

Regeneron Pharmaceuticals announced the U.S. FDA has accepted for Priority Review the supplemental Biologics License Application for Evkeeza as an adjunct to other lipid-lowering therapies to treat children aged 5 to 11 years with homozygous familial hypercholesterolemia. The FDA target action date is March 30, 2023.

ShowHide Related Items >><<
REGN Regeneron
$736.08 /

-5.545 (-0.75%)

REGN Regeneron
$736.08 /

-5.545 (-0.75%)

11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/09/22 Truist
Regeneron price target raised to $856 from $790 at Truist
11/03/22 Piper Sandler
Regeneron price target lowered to $765 from $775 at Piper Sandler
10/31/22 EF Hutton
Regeneron initiated with a Buy at EF Hutton
REGN Regeneron
$736.08 /

-5.545 (-0.75%)

REGN Regeneron
$736.08 /

-5.545 (-0.75%)

REGN Regeneron
$736.08 /

-5.545 (-0.75%)

REGN Regeneron
$736.08 /

-5.545 (-0.75%)

Recommendations
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo » 07:22
11/30/22
11/30
07:22
11/30/22
07:22
HZNP

Horizon Therapeutics

/

+

, SNY

Sanofi

$45.89 /

+0.33 (+0.72%)

, JNJ

Johnson & Johnson

$176.04 /

-1.26 (-0.71%)

, AMGN

Amgen

$282.00 /

-0.67 (-0.24%)

Wells Fargo analyst Derek…

Wells Fargo analyst Derek Archila reiterates an Overweight rating after Horizon Therapeutics (HZNP) announced it has fielded takeover interest from multiple Big Pharma companies - Sanofi (SNY), Johnson & Johnson (JNJ), and Amgen (AMGN) were cited -- and is engaged in "highly" preliminary discussions. Since Horizon is Irish domiciled, Irish takeover rules require the "possible offerers" to state their intention of either making an offer or not, no later than Jan 10, 2023, the analyst adds. This doesn't mean a deal will get done, but he is "not incredibly surprised" about the interest, given the meaningful discount Archila thinks shares currently trade. The analyst believes fair value in a takeover could be about $135/share based on his quick math. Further, he thinks Horizon's deep immunology franchise and pipeline would fit with all the aforementioned companies.

ShowHide Related Items >><<
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
/

+

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

HZNP Horizon Therapeutics
/

+

11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
10/25/22 Piper Sandler
Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
08/18/22 BofA
Horizon Therapeutics and Spirit AeroSystems removed from US 1 List at BOFA
08/04/22 BMO Capital
Horizon Therapeutics price target lowered to $117 from $145 at BMO Capital
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
10/06/22 Chardan
Provention co-promotion deal reinforces Chardan's confidence in teplizumab
JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
11/02/22 Morgan Stanley
Abiomed upgraded to Equal Weight from Underweight at Morgan Stanley
AMGN Amgen
$282.00 /

-0.67 (-0.24%)

11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
11/08/22 Oppenheimer
Amgen price target raised to $300 from $290 at Oppenheimer
11/08/22 Truist
Amgen price target raised to $280 from $266 at Truist
11/04/22 Piper Sandler
Amgen price target raised to $278 from $265 at Piper Sandler
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
/

+

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
/

+

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
/

+

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

Hot Stocks
Sanofi reports Phase II/III study results for acoziborole published in Lancet » 06:52
11/30/22
11/30
06:52
11/30/22
06:52
SNY

Sanofi

$45.89 /

+0.33 (+0.72%)

The Drugs for Neglected…

The Drugs for Neglected Diseases initiative, or DNDi, and Sanofi announce treatment success rates of up to 95% from a Phase II/III study investigating the safety and efficacy of single-dose acoziborole, an investigational treatment for sleeping sickness, published today in The Lancet Infectious Diseases medical journal. The clinical trial was led by DNDi and its partners in the Democratic Republic of the Congo and Guinea. "Between 2016 and 2019, DNDi and its partners led an open-label, Phase II/III study to assess the safety and efficacy of acoziborole in patients with early- and late-stage g-HAT. 208 patients were recruited at 10 hospitals in the DRC and Guinea. The 18-month treatment success rate for acoziborole was 95% in late-stage g-HAT patients, corresponding to the best results from studies with existing treatments of 94%. In addition, 100% of the 41 patients with early-stage g-HAT were considered as treatment successes at all timepoints. The study shows that acoziborole has a favourable safety profile, with no significant drug-related safety signals reported. These pivotal results will form the basis of Sanofi's dossier submission to the European Medicines Agency (EMA) and represent another milestone in the quest to eliminate sleeping sickness. Upon the EMA's positive opinion and local approval, Sanofi will donate acoziborole to the WHO through its philanthropic organization, Foundation S - The Sanofi Collective. Acoziborole is currently under clinical investigation and its safety and efficacy have not been evaluated by any regulatory authority," the company stated.

ShowHide Related Items >><<
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
10/06/22 Chardan
Provention co-promotion deal reinforces Chardan's confidence in teplizumab
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

Tuesday
Hot Stocks
Horizon Therapeutics jumps 33% after deal talks with Amgen, Janssen, Sanofi » 17:00
11/29/22
11/29
17:00
11/29/22
17:00
HZNP

Horizon Therapeutics

$78.78 /

+0.69 (+0.88%)

, AMGN

Amgen

$282.00 /

-0.67 (-0.24%)

, JNJ

Johnson & Johnson

$176.04 /

-1.26 (-0.71%)

, SNY

Sanofi

$45.89 /

+0.33 (+0.72%)

In after-hours trading,…

In after-hours trading, shares are up 33% to $104.99.

ShowHide Related Items >><<
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
10/25/22 Piper Sandler
Horizon Therapeutics price target lowered to $88 from $90 at Piper Sandler
08/18/22 BofA
Horizon Therapeutics and Spirit AeroSystems removed from US 1 List at BOFA
08/04/22 BMO Capital
Horizon Therapeutics price target lowered to $117 from $145 at BMO Capital
AMGN Amgen
$282.00 /

-0.67 (-0.24%)

11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
11/08/22 Oppenheimer
Amgen price target raised to $300 from $290 at Oppenheimer
11/08/22 Truist
Amgen price target raised to $280 from $266 at Truist
11/04/22 Piper Sandler
Amgen price target raised to $278 from $265 at Piper Sandler
JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
11/02/22 Morgan Stanley
Abiomed upgraded to Equal Weight from Underweight at Morgan Stanley
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

11/14/22 Oppenheimer
Biogen price target raised to $315 from $300 at Oppenheimer
10/14/22 Barclays
Sanofi price target lowered to EUR 85 from EUR 105 at Barclays
10/06/22 Jefferies
Provention Bio price target raised to $15 from $10 at Jefferies
10/06/22 Chardan
Provention co-promotion deal reinforces Chardan's confidence in teplizumab
SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

HZNP Horizon Therapeutics
$78.78 /

+0.69 (+0.88%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

SNY Sanofi
$45.89 /

+0.33 (+0.72%)

JNJ Johnson & Johnson
$176.04 /

-1.26 (-0.71%)

AMGN Amgen
$282.00 /

-0.67 (-0.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.